Results 241 to 250 of about 3,367,821 (256)

JAK2 kinase inhibitors and myeloproliferative disorders

Current opinion in hematology, 2010
Andrew Chen, J. Prchal
semanticscholar   +1 more source

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith
exaly  

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Ca-A Cancer Journal for Clinicians, 2016
Carol E Desantis, Ann Goding Sauer Msph, Robert A Smith   +2 more
exaly  

Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.

Scandinavian Journal of Haematology, 2009
B. Boneu, C. Nouvel, P. Sié, C. Caranobe, D. Combes, G. Laurent, J. Pris, R. Bierme   +7 more
semanticscholar   +1 more source

Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2015
Robert A Smith
exaly  

[Myeloproliferative disorders].

Medizinische Klinik, 1972
G, Hartwich, H, Lutz
openaire   +1 more source

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2018
Robert A Smith, Stacey A Fedewa, Otis W Brawley   +2 more
exaly  

Myeloproliferative disorders.

Clinics in laboratory medicine, 1991
openaire   +1 more source

MYELOPROLIFERATIVE DISORDERS

Annals of Internal Medicine, 1969
openaire   +1 more source

Myeloproliferative Syndromes (Chronic Myeloproliferative Disorders)

2005
openaire   +1 more source